Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.560
-0.030 (-1.16%)
Mar 13, 2026, 9:30 AM EDT - Market open
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $144.23 million as of March 13, 2026. Its market cap has increased by 231.56% in one year.
Market Cap
144.23M
Enterprise Value
100.65M
1-Year Change
231.56%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $144.23M, a decrease of -6.41%. That is a compound annual growth rate of -0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 145.90M | 11.12% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 151.73M |
| Innate Pharma | 149.94M |
| Artiva Biotherapeutics | 147.27M |
| Cardiff Oncology | 138.44M |
| Oramed Pharmaceuticals | 133.74M |
| Aardvark Therapeutics | 130.64M |
| AN2 Therapeutics | 128.93M |
| Precision BioSciences | 128.78M |